NFKB1 and Alzheimer disease: The non-steroidal anti-inflammatory drug (NSAID) Flurbiprofen, an NFκB inhibitor, suppressed β-secretase activity and effectively reduced Aβ1–42 levels [25] as well as Aβ amyloid plaque formation in AD transgenic mice [26].